Moreover, in gliomas, the inhibition of CXCR4 leads to the disruption of the sonic hedgehog (SHH)-GLI-NANOG network [59], and is crucial for maintaining the self-renewal, proliferation, therapeutic resistance, and angiogenesis of glioblastoma cells in rat [60]. This evidence concerns the gene CXCR4 and central nervous system cancer.